Help Shape the Future of Veterinary Education
|Articles|December 13, 2007

Trilostane: A new treatment option for dogs with hyperadrenocorticism (1:40)

"The advantage of trilostane seems to be a much higher safety profile than Lysodren with an equal efficacy rate."


Related to this article